Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rezina Arju
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
Clinical Breast Cancer
Cancer Research
Oncology
Related publications
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers After Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Cancer Discovery
Oncology
Therapeutic Targets: MTOR and Related Pathways
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Impact of Molecular Subtype Conversion of Breast Cancers After Neoadjuvant Chemotherapy on Clinical Outcome
Cancer Research and Treatment
Cancer Research
Oncology
Molecular Pathways and Therapeutic Targets in Lung Cancer
Oncotarget
Oncology
Differences Between Invasive Lobular and Invasive Ductal Carcinoma of the Breast: Results and Therapeutic Implications
Therapeutic Advances in Medical Oncology
Oncology
Clinical Benefit From Neoadjuvant Chemotherapy in Oestrogen Receptor-Positive Invasive Ductal and Lobular Carcinomas
British Journal of Cancer
Cancer Research
Oncology
Clinical Significance and Prognostic Value of Receptor Conversion in Hormone Receptor Positive Breast Cancers After Neoadjuvant Chemotherapy
World Journal of Surgical Oncology
Surgery
Oncology
Elucidating Therapeutic Molecular Targets in Premenopausal Asian Women With Recurrent Breast Cancers
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
STAT3 and STAT5A Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
Oncotarget
Oncology
